不可手术治疗的III期非小细胞肺癌老年患者的治疗模式:基于国家癌症数据库的分析
基于国家癌症数据库(NCDB)2003–2014年数据,比较老年(≥70岁)与非老年(<70岁)不可手术治疗的III期非小细胞肺癌(NSCLC)患者的治疗模式。老年患者接受任何治疗及根治性治疗的比例均低于非老年患者,且接受同步放化疗(CCRT)的比例显著更低。
要点
- 老年(≥70岁)不可手术III期NSCLC患者接受未治疗的比例为24.5%,高于非老年患者的13.2%(P<0.0001)。
- 老年患者接受根治性治疗的比例为48.5%,低于非老年患者的56.3%(P<0.0001)。
- 在根治性治疗患者中,老年患者接受同步放化疗的比例为66.0%,低于非老年患者的78.9%(P<0.0001)。
核心结论
- 在不可手术治疗的III期NSCLC患者中,老年患者接受任何治疗或根治性治疗的可能性均低于非老年患者。
- 老年III期NSCLC患者中同步或序贯化疗的使用不足,提示该脆弱人群的最佳治疗方式尚未明确。
研究设计与样本
- 基于国家癌症数据库(NCDB)2003–2014年数据的分析。
- 纳入不可手术治疗的III期NSCLC患者,定义老年为≥70岁,非老年为<70岁。
- 治疗分类包括:未治疗、姑息治疗(单纯化疗、放疗<59.4 Gy或放化疗<59.4 Gy)、根治性治疗(单纯放疗≥59.4 Gy或放化疗≥59.4 Gy)。
- 采用χ2检验比较老年与非老年患者治疗差异。
主要发现
- 共纳入57,602例老年患者和55,928例非老年患者。
- 老年患者接受未治疗的比例为24.5%,非老年患者为13.2%(P<0.0001)。
- 老年患者接受根治性治疗的比例为48.5%,非老年患者为56.3%(P<0.0001)。
- 在根治性治疗患者中,老年患者接受同步放化疗的比例为66.0%,非老年患者为78.9%(P<0.0001)。
- 在接受任何治疗的患者中,老年患者接受同步放化疗的比例为32.0%,非老年患者为44.5%(P<0.0001);在所有患者中,老年患者为24.2%,非老年患者为38.6%(P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare patterns of care for elderly patients versus non-elderly patients with non-surgically treated stage III non-small cell lung cancer (NSCLC) using the National Cancer Database (NCDB). We hypothesize that elderly patients are less likely to receive curative treatments, including concurrent chemoradiation (CCRT), compared to non-elderly patients. METHODS: We identified patients from the NCDB between 2003 and 2014 with non-surgically treated stage III NSCLC. We defined elderly as ≥70 years old and non-elderly <70 years old. Treatment categories included: no treatment, palliative treatment (chemotherapy alone, radiation (RT) alone <59.4 Gy or chemoradiation (CRT) <59.4 Gy), or definitive treatment (RT alone ≥59.4 Gy or CRT ≥59.4 Gy). Differences in treatment between elderly and non-elderly were tested using the χ2 test. RESULTS: We identified 57,602 elderly and 55,928 non-elderly patients. More elderly patients received no treatment (24.5% vs. 13.2%, P < 0.0001) and the elderly were less likely to receive definitive treatment (48.5% vs. 56.3%, P < 0.0001). CCRT was delivered in a significantly smaller proportion of elderly vs. non-elderly patients (66.0% vs. 78.9%, P < 0.0001 in patients treated with definitive intent; 32.0% vs. 44.5%, P < 0.0001 in patients receiving any treatment; and 24.2% vs. 38.6%, P < 0.0001 amongst all patients). CONCLUSIONS: In this large study of patients with non-surgically treated stage III NSCLC, elderly patients were less likely to receive any treatment or treatment with definitive intent compared to the non-elderly. The lack of use of concurrent or sequential chemotherapy in the elderly with stage III NSCLC suggests that the optimal treatment approach for this vulnerable population remains undefined.
引用
- Miller ED, Fisher JL, Haglund KE, et al. Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database. Radiat Oncol. 2018. PMID: 30290823. doi:10.1186/s13014-018-1142-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。